Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction-Reference-Cited by-同舟云学术

Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction

Published:2022-09 Issue:9 Volume:22 Page:2169-2179
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:American Journal of Transplantation

Author:

Shino Michael Y.^ORCID,Todd Jamie L.^ORCID,Neely Megan L.,Kirchner Jerry,Frankel Courtney W.,Snyder Laurie D.^ORCID,Pavlisko Elizabeth N.,Fishbein Gregory A.^ORCID,Schaenman Joanna M.^ORCID,Mason Kristen,Kesler Karen,Martinu Tereza,Singer Lianne G.^ORCID,Tsuang Wayne^ORCID,Budev Marie,Shah Pali D.,Reynolds John M.,Williams Nikki,Robien Mark A.,Palmer Scott M.^ORCID,Weigt S. Sam,Belperio John A.

Funder

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajt.17108

Reference32 articles.

1. The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report—2017; focus theme: allograft ischemic time;Chambers;J Hear Lung Transplant.,2017

2. Interstitial inflammatory lesions of the pulmonary allograft: a retrospective analysis of 2697 transbronchial biopsies;Burton;Transplant.,2008

3. Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation;Davis;Am J Transplant.,2012